The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Famciclovir-Global Market Insights and Sales Trends 2025
Synopsis
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Famciclovir in various end use industries. The expanding demands from the Cold Sores, Genital Herpes and Shingles,, are propelling Famciclovir market. 125 mg Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 250 mg Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Famciclovir market, driven by demand from China, the second largest economy with some signs of stabilising, the Famciclovir market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Famciclovir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Famciclovir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Famciclovir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Famciclovir covered in this report include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc.
The global Famciclovir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Global Famciclovir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Famciclovir market, Segment by Type:
125 mg Tablets
250 mg Tablets
500 mg Tablets
Global Famciclovir market, by Application
Cold Sores
Genital Herpes
Shingles
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Famciclovir in various end use industries. The expanding demands from the Cold Sores, Genital Herpes and Shingles,, are propelling Famciclovir market. 125 mg Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 250 mg Tablets segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Famciclovir market, driven by demand from China, the second largest economy with some signs of stabilising, the Famciclovir market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Famciclovir market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Famciclovir market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Famciclovir sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Famciclovir covered in this report include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc.
The global Famciclovir market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Global Famciclovir market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Famciclovir market, Segment by Type:
125 mg Tablets
250 mg Tablets
500 mg Tablets
Global Famciclovir market, by Application
Cold Sores
Genital Herpes
Shingles
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Famciclovir Market Overview
1.1 Famciclovir Product Overview
1.2 Famciclovir Market Segment by Type
1.2.1 125 mg Tablets
1.2.2 250 mg Tablets
1.2.3 500 mg Tablets
1.3 Global Famciclovir Market Size by Type
1.3.1 Global Famciclovir Market Size Overview by Type (2018-2029)
1.3.2 Global Famciclovir Historic Market Size Review by Type (2018-2023)
1.3.3 Global Famciclovir Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Famciclovir Sales Breakdown by Type (2018-2023)
1.4.2 Europe Famciclovir Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Famciclovir Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Famciclovir Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Famciclovir Sales Breakdown by Type (2018-2023)
2 Global Famciclovir Market Competition by Company
2.1 Global Top Players by Famciclovir Sales (2018-2023)
2.2 Global Top Players by Famciclovir Revenue (2018-2023)
2.3 Global Top Players by Famciclovir Price (2018-2023)
2.4 Global Top Manufacturers Famciclovir Manufacturing Base Distribution, Sales Area, Product Type
2.5 Famciclovir Market Competitive Situation and Trends
2.5.1 Famciclovir Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Famciclovir Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Famciclovir as of 2022)
2.7 Date of Key Manufacturers Enter into Famciclovir Market
2.8 Key Manufacturers Famciclovir Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Famciclovir Status and Outlook by Region
3.1 Global Famciclovir Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Famciclovir Historic Market Size by Region
3.2.1 Global Famciclovir Sales in Volume by Region (2018-2023)
3.2.2 Global Famciclovir Sales in Value by Region (2018-2023)
3.2.3 Global Famciclovir Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Famciclovir Forecasted Market Size by Region
3.3.1 Global Famciclovir Sales in Volume by Region (2024-2029)
3.3.2 Global Famciclovir Sales in Value by Region (2024-2029)
3.3.3 Global Famciclovir Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Famciclovir by Application
4.1 Famciclovir Market Segment by Application
4.1.1 Cold Sores
4.1.2 Genital Herpes
4.1.3 Shingles
4.2 Global Famciclovir Market Size by Application
4.2.1 Global Famciclovir Market Size Overview by Application (2018-2029)
4.2.2 Global Famciclovir Historic Market Size Review by Application (2018-2023)
4.2.3 Global Famciclovir Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Famciclovir Sales Breakdown by Application (2018-2023)
4.3.2 Europe Famciclovir Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Famciclovir Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Famciclovir Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Famciclovir Sales Breakdown by Application (2018-2023)
5 North America Famciclovir by Country
5.1 North America Famciclovir Historic Market Size by Country
5.1.1 North America Famciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Famciclovir Sales in Volume by Country (2018-2023)
5.1.3 North America Famciclovir Sales in Value by Country (2018-2023)
5.2 North America Famciclovir Forecasted Market Size by Country
5.2.1 North America Famciclovir Sales in Volume by Country (2024-2029)
5.2.2 North America Famciclovir Sales in Value by Country (2024-2029)
6 Europe Famciclovir by Country
6.1 Europe Famciclovir Historic Market Size by Country
6.1.1 Europe Famciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Famciclovir Sales in Volume by Country (2018-2023)
6.1.3 Europe Famciclovir Sales in Value by Country (2018-2023)
6.2 Europe Famciclovir Forecasted Market Size by Country
6.2.1 Europe Famciclovir Sales in Volume by Country (2024-2029)
6.2.2 Europe Famciclovir Sales in Value by Country (2024-2029)
7 Asia-Pacific Famciclovir by Region
7.1 Asia-Pacific Famciclovir Historic Market Size by Region
7.1.1 Asia-Pacific Famciclovir Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Famciclovir Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Famciclovir Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Famciclovir Forecasted Market Size by Region
7.2.1 Asia-Pacific Famciclovir Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Famciclovir Sales in Value by Region (2024-2029)
8 Latin America Famciclovir by Country
8.1 Latin America Famciclovir Historic Market Size by Country
8.1.1 Latin America Famciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Famciclovir Sales in Volume by Country (2018-2023)
8.1.3 Latin America Famciclovir Sales in Value by Country (2018-2023)
8.2 Latin America Famciclovir Forecasted Market Size by Country
8.2.1 Latin America Famciclovir Sales in Volume by Country (2024-2029)
8.2.2 Latin America Famciclovir Sales in Value by Country (2024-2029)
9 Middle East and Africa Famciclovir by Country
9.1 Middle East and Africa Famciclovir Historic Market Size by Country
9.1.1 Middle East and Africa Famciclovir Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Famciclovir Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Famciclovir Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Famciclovir Forecasted Market Size by Country
9.2.1 Middle East and Africa Famciclovir Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Famciclovir Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Famciclovir Products Offered
10.1.5 Novartis Recent Development
10.2 Mylan
10.2.1 Mylan Company Information
10.2.2 Mylan Introduction and Business Overview
10.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Mylan Famciclovir Products Offered
10.2.5 Mylan Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Teva Famciclovir Products Offered
10.3.5 Teva Recent Development
10.4 Cipla
10.4.1 Cipla Company Information
10.4.2 Cipla Introduction and Business Overview
10.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cipla Famciclovir Products Offered
10.4.5 Cipla Recent Development
10.5 Hikma
10.5.1 Hikma Company Information
10.5.2 Hikma Introduction and Business Overview
10.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hikma Famciclovir Products Offered
10.5.5 Hikma Recent Development
10.6 Apotex
10.6.1 Apotex Company Information
10.6.2 Apotex Introduction and Business Overview
10.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Apotex Famciclovir Products Offered
10.6.5 Apotex Recent Development
10.7 Aurobindo Pharma
10.7.1 Aurobindo Pharma Company Information
10.7.2 Aurobindo Pharma Introduction and Business Overview
10.7.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Aurobindo Pharma Famciclovir Products Offered
10.7.5 Aurobindo Pharma Recent Development
10.8 Macleods Pharmaceuticals
10.8.1 Macleods Pharmaceuticals Company Information
10.8.2 Macleods Pharmaceuticals Introduction and Business Overview
10.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Macleods Pharmaceuticals Famciclovir Products Offered
10.8.5 Macleods Pharmaceuticals Recent Development
10.9 Beijing Jialin Pharmaceutical
10.9.1 Beijing Jialin Pharmaceutical Company Information
10.9.2 Beijing Jialin Pharmaceutical Introduction and Business Overview
10.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beijing Jialin Pharmaceutical Famciclovir Products Offered
10.9.5 Beijing Jialin Pharmaceutical Recent Development
10.10 HETERO
10.10.1 HETERO Company Information
10.10.2 HETERO Introduction and Business Overview
10.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.10.4 HETERO Famciclovir Products Offered
10.10.5 HETERO Recent Development
10.11 Hainan choitec Pharmaceuticals
10.11.1 Hainan choitec Pharmaceuticals Company Information
10.11.2 Hainan choitec Pharmaceuticals Introduction and Business Overview
10.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hainan choitec Pharmaceuticals Famciclovir Products Offered
10.11.5 Hainan choitec Pharmaceuticals Recent Development
10.12 Shandong Luoxin Pharmaceutical Group
10.12.1 Shandong Luoxin Pharmaceutical Group Company Information
10.12.2 Shandong Luoxin Pharmaceutical Group Introduction and Business Overview
10.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Products Offered
10.12.5 Shandong Luoxin Pharmaceutical Group Recent Development
10.13 Chengdu Diao Pharmaceutical Group
10.13.1 Chengdu Diao Pharmaceutical Group Company Information
10.13.2 Chengdu Diao Pharmaceutical Group Introduction and Business Overview
10.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Products Offered
10.13.5 Chengdu Diao Pharmaceutical Group Recent Development
10.14 HISUN
10.14.1 HISUN Company Information
10.14.2 HISUN Introduction and Business Overview
10.14.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2018-2023)
10.14.4 HISUN Famciclovir Products Offered
10.14.5 HISUN Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Famciclovir Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Famciclovir Industrial Chain Analysis
11.4 Famciclovir Market Dynamics
11.4.1 Famciclovir Industry Trends
11.4.2 Famciclovir Market Drivers
11.4.3 Famciclovir Market Challenges
11.4.4 Famciclovir Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Famciclovir Distributors
12.3 Famciclovir Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
